Heron Therapeutics, Inc. (HRTX)
0.3111
-0.01
(-4.54%)
USD |
NASDAQ |
Nov 13, 16:00
0.31
0.00 (0.00%)
After-Hours: 19:59
Heron Therapeutics Total Assets (Quarterly) : 230.45M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 230.45M |
| June 30, 2026 | 252.26M |
| March 31, 2026 | 246.22M |
| December 31, 2025 | 670.88M |
| September 30, 2025 | 248.95M |
| June 30, 2025 | 232.09M |
| March 31, 2025 | 235.75M |
| December 31, 2024 | 233.15M |
| September 30, 2024 | 220.78M |
| June 30, 2024 | 218.14M |
| March 31, 2024 | 217.89M |
| December 31, 2023 | 222.51M |
| September 30, 2023 | 229.20M |
| June 30, 2023 | 201.22M |
| March 31, 2023 | 220.88M |
| December 31, 2022 | 250.95M |
| September 30, 2022 | 271.95M |
| June 30, 2022 | 243.96M |
| March 31, 2022 | 273.72M |
| December 31, 2021 | 305.71M |
| September 30, 2021 | 352.39M |
| June 30, 2021 | 404.25M |
| March 31, 2021 | 310.93M |
| December 31, 2020 | 353.56M |
| September 30, 2020 | 390.02M |
| Date | Value |
|---|---|
| June 30, 2020 | 432.72M |
| March 31, 2020 | 478.94M |
| December 31, 2019 | 512.78M |
| September 30, 2019 | 392.96M |
| June 30, 2019 | 411.67M |
| March 31, 2019 | 435.79M |
| December 31, 2018 | 462.18M |
| September 30, 2018 | 470.90M |
| June 30, 2018 | 510.56M |
| March 31, 2018 | 183.38M |
| December 31, 2017 | 234.31M |
| September 30, 2017 | 118.20M |
| June 30, 2017 | 142.37M |
| March 31, 2017 | 189.56M |
| December 31, 2016 | 67.48M |
| September 30, 2016 | 98.81M |
| June 30, 2016 | 85.73M |
| March 31, 2016 | 111.85M |
| December 31, 2015 | 137.84M |
| September 30, 2015 | 158.15M |
| June 30, 2015 | 176.46M |
| March 31, 2015 | 59.63M |
| December 31, 2014 | 76.68M |
| September 30, 2014 | 92.28M |
| June 30, 2014 | 108.64M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Tonix Pharmaceuticals Holding Corp. | 242.43M |
| Ionis Pharmaceuticals, Inc. | 2.913B |
| TG Therapeutics, Inc. | 1.592B |
| Karyopharm Therapeutics, Inc. | 111.32M |
| Minerva Neurosciences, Inc. | 98.28M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 225.53M |
| Shareholders Equity (Quarterly) | 4.916M |
| Debt to Equity Ratio | 26.80 |
| Current Ratio | 2.327 |
| Net Debt Paydown Yield | 15.12% |